Adapted Corona vaccine from BioNTech and Pfizer on the way » Leadersnet
| Editorial staff | 22.09.2024 Approval by the European Commission is still pending, but a corresponding recommendation has now been received by the authority for review. The new vaccine is adapted to the KP.2 variant, which is particularly prevalent in early summer, but should also offer increased protection against the virus type that is currently … Read more